$0.475100
-0.02-3.24%
At Close: -
$0.470200
-0.0049-1.03%
After Hours: Sep 20, 7:57 PM EDT
15 minutes delayed
Enveric Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Enveric Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $-0.23 | $-0.55 | 58.2 % |
Mar 2024 | 2024-05-15 | $-0.61 | $-1.28 | 52.3 % |
Dec 2023 | 2024-03-26 | $-1.47 | $-1.54 | 4.55 % |
Sep 2023 | 2023-11-13 | $-1.30 | $-2.09 | 37.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Enveric Biosciences (ENVB) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $-0.23, which beat the estimate of $-0.55.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.